Search This Blog

Tuesday, November 5, 2019

Apellis Pharmaceuticals EPS misses by $0.09

Apellis Pharmaceuticals (NASDAQ:APLS): Q3 GAAP EPS of -$1.10 misses by $0.09.
Cash and cash equivalents of $434M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)